{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:29:46Z","timestamp":1790998186891,"version":"4.1.0"},"reference-count":215,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.apsb.2026.03.044","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:11:23Z","timestamp":1774858283000},"page":"3257-3291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent advances in antiviral drugs for Chikungunya virus (CHIKV): Targets, mechanisms, and development strategies"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-6381","authenticated-orcid":false,"given":"Xiaowen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.03.044_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70013","article-title":"Multiorgan proteomic analysis of infected animal models predict potential host factors for chikungunya virus","volume":"6","author":"Lin","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.apsb.2026.03.044_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/srep14179","article-title":"Activity of andrographolide against chikungunya virus infection","volume":"5","author":"Wintachai","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.044_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104954","article-title":"Betulinic acid exhibits antiviral effects against dengue virus infection","volume":"184","author":"Loe","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib4","doi-asserted-by":"crossref","first-page":"dmm049804","DOI":"10.1242\/dmm.049804","article-title":"Evolution and immunopathology of chikungunya virus informs therapeutic development","volume":"16","author":"Henderson Sousa","year":"2023","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.apsb.2026.03.044_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2595790","article-title":"Isolation and genomic characterization of Chikungunya virus during the 2025 outbreak in Foshan, China","volume":"14","author":"Sun","year":"2025","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.apsb.2026.03.044_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2017.12.012","article-title":"Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection","volume":"150","author":"Oo","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29276","article-title":"Evaluation of renal markers and liver enzymes in patients infected with the Chikungunya virus","volume":"95","author":"Soares","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.apsb.2026.03.044_bib8","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/v13071307","article-title":"Antivirals against the Chikungunya virus","volume":"13","author":"Battisti","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2026.03.044_bib9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1172\/JCI134746","article-title":"Chikungunya infection: de-linking replication from symptomatology reveals the central role of muscle","volume":"130","author":"Moscona","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.03.044_bib10","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3390\/v16121902","article-title":"Cardiac biomarkers in a Brazilian Indigenous population exposed to arboviruses: a cross-sectional study","volume":"16","author":"Nicacio","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2026.03.044_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/1386207323999200818165029","article-title":"Andrographolide mitigates unfolded protein response pathway and apoptosis involved in Chikungunya virus infection","volume":"24","author":"Gupta","year":"2021","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.1016\/j.apsb.2026.03.044_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.r1277","article-title":"UK pauses chikungunya vaccine (IXCHIQ) in over 65s to conduct safety review","volume":"389","author":"Iacobucci","year":"2025","journal-title":"Bmj"},{"key":"10.1016\/j.apsb.2026.03.044_bib13","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(25)00372-1","article-title":"Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial","volume":"405","author":"Tindale","year":"2025","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.apsb.2026.03.044_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(25)00345-9","article-title":"Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial","volume":"405","author":"Richardson","year":"2025","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.apsb.2026.03.044_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2015.06.013","article-title":"Suramin inhibits chikungunya virus replication through multiple mechanisms","volume":"121","author":"Albulescu","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2019.04.098","article-title":"Intraviral interactome of Chikungunya virus reveals the homo-oligomerization and palmitoylation of structural protein TF","volume":"513","author":"Yin","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2026.03.044_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s13337-019-00547-0","article-title":"In silico study of chikungunya polymerase, a potential target for inhibitors","volume":"30","author":"Ghildiyal","year":"2019","journal-title":"Virusdisease"},{"key":"10.1016\/j.apsb.2026.03.044_bib18","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1021\/acs.est.4c09860","article-title":"Environmental surveillance of vector-borne diseases in a non-sewered system: a case study in Mozambique","volume":"59","author":"Monteiro","year":"2025","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.apsb.2026.03.044_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/1735-5362.288437","article-title":"Exploration of small-molecule entry disruptors for chikungunya virus by targeting matrix remodelling associated protein","volume":"15","author":"Kumar","year":"2020","journal-title":"Res Pharm Sci"},{"key":"10.1016\/j.apsb.2026.03.044_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12985-016-0607-2","article-title":"Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry","volume":"13","author":"Hen\u00df","year":"2016","journal-title":"Virol J"},{"key":"10.1016\/j.apsb.2026.03.044_bib21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/v12070722","article-title":"Cathepsin B protease facilitates Chikungunya virus envelope protein-mediated infection via endocytosis or macropinocytosis","volume":"12","author":"Izumida","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2026.03.044_bib22","doi-asserted-by":"crossref","first-page":"7382","DOI":"10.1128\/AAC.01421-16","article-title":"Design and validation of novel Chikungunya virus protease inhibitors","volume":"60","author":"Das","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2026.03.044_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150393","article-title":"Inhibition of early RNA replication in Chikungunya and Dengue virus by lycorine: in vitro and in silico studies","volume":"730","author":"Agrawal","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2026.03.044_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83042","article-title":"Architecture of the chikungunya virus replication organelle","volume":"11","author":"Laurent","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.apsb.2026.03.044_bib25","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bbrc.2017.09.142","article-title":"Key components of COPI and COPII machineries are required for chikungunya virus replication","volume":"493","author":"Zhang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2026.03.044_bib26","doi-asserted-by":"crossref","first-page":"21899","DOI":"10.1074\/jbc.M802444200","article-title":"Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein","volume":"283","author":"Ozden","year":"2008","journal-title":"Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib27","doi-asserted-by":"crossref","first-page":"10255","DOI":"10.1128\/JVI.01507-13","article-title":"The role of E3 in pH protection during alphavirus assembly and exit","volume":"87","author":"Uchime","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2026.03.044_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01986-24","article-title":"The alphavirus determinants of intercellular long extension formation","volume":"16","author":"Martin","year":"2025","journal-title":"mBio"},{"key":"10.1016\/j.apsb.2026.03.044_bib29","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1021\/acsomega.0c06191","article-title":"1,3-Thiazolbenzamide derivatives as Chikungunya virus nsP2 protease inhibitors","volume":"6","author":"Ivanova","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.apsb.2026.03.044_bib30","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-025-59402-0","article-title":"Saddle curvature association of nsP1 facilitates the replication complex assembly of Chikungunya virus in cells","volume":"16","author":"Miao","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.03.044_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.antiviral.2018.03.013","article-title":"Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme","volume":"154","author":"Feibelman","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1873-3468.13642","article-title":"Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase","volume":"594","author":"Mudgal","year":"2020","journal-title":"FEBS (Fed Eur Biochem Soc) Lett"},{"key":"10.1016\/j.apsb.2026.03.044_bib33","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1128\/jvi.71.1.392-397.1997","article-title":"Critical residues of Semliki Forest virus RNA capping enzyme involved in methyltransferase and guanylyltransferase-like activities","volume":"71","author":"Ahola","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2026.03.044_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2213934120","article-title":"Structural basis and dynamics of Chikungunya alphavirus RNA capping by nsP1 capping pores","volume":"120","author":"Jones","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.03.044_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2021.02.018","article-title":"Structural insights into viral RNA capping and plasma membrane targeting by Chikungunya virus nonstructural protein 1","volume":"29","author":"Zhang","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.apsb.2026.03.044_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02532-19","article-title":"6\u2032-\u03b2-Fluoro-homoaristeromycin and 6\u2032-fluoro-homoneplanocin A are potent inhibitors of Chikungunya virus replication through their direct effect on viral nonstructural protein 1","volume":"64","author":"Kovacikova","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2026.03.044_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111956","article-title":"Identification of 6\u2032-\u03b2-fluoro-homoaristeromycin as a potent inhibitor of chikungunya virus replication","volume":"187","author":"Shin","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00135-21","article-title":"Radicicol inhibits Chikungunya virus replication by targeting nonstructural protein 2","volume":"65","author":"Nam","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2026.03.044_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129949","article-title":"Drugs targeting structural and nonstructural proteins of the chikungunya virus: a review","volume":"262","author":"Wang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.apsb.2026.03.044_bib40","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/v14071351","article-title":"The antifungal itraconazole is a potent inhibitor of Chikungunya virus replication","volume":"14","author":"Policastro","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2026.03.044_bib41","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.1021\/acs.jmedchem.5c00635","article-title":"Identification of direct-acting nsP2 helicase inhibitors with antialphaviral activity","volume":"68","author":"Muthu","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib42","article-title":"Discovery of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach","author":"Merten","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2026.03.044_bib43","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1074\/jbc.M113.503433","article-title":"Functional cross-talk between distant domains of chikungunya virus non-structural protein 2 is decisive for its RNA-modulating activity","volume":"289","author":"Das","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.034","article-title":"Structural basis for RNA replication by the SARS-CoV-2 polymerase","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.03.044_bib45","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41467-019-09523-0","article-title":"Specific inhibition of splicing factor activity by decoy RNA oligonucleotides","volume":"10","author":"Denichenko","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.03.044_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biochi.2018.04.004","article-title":"Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease","volume":"149","author":"Singh","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.apsb.2026.03.044_bib47","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijbiomac.2018.05.007","article-title":"Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site","volume":"116","author":"Narwal","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.apsb.2026.03.044_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02062-18","article-title":"Novel mutations in nsP2 abolish Chikungunya virus-induced transcriptional shutoff and make the virus less cytopathic without affecting its replication rates","volume":"93","author":"Akhrymuk","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2026.03.044_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116808","article-title":"Inhibitor of the non-structural protein 2 protease shows promising efficacy in mouse models of chikungunya","volume":"278","author":"Metibemu","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib50","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409166121","article-title":"Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach","volume":"121","author":"Merten","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.03.044_bib51","doi-asserted-by":"crossref","unstructured":"Ghoshal A, Asressu KH, Hossain MA, Brown PJ, Merten EM, Sears JD, et al. Structure activity of \u03b2-amidomethyl vinyl sulfones as covalent inhibitors of Chikungunya nsP2 cysteine protease with anti-alphavirus activity. bioRxiv 2024. Available from: https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.4c01346.","DOI":"10.1101\/2024.06.12.598722"},{"key":"10.1016\/j.apsb.2026.03.044_bib52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/pathogens8030128","article-title":"Targeting the nsp2 cysteine protease of Chikungunya virus using FDA approved library and selected cysteine protease inhibitors","volume":"8","author":"Kumar","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.apsb.2026.03.044_bib53","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409166121","article-title":"Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach","volume":"121","author":"Merten","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.03.044_bib54","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1021\/acsinfecdis.5c00351","article-title":"Enantioselective chemical probe for Chikungunya nsP2 helicase with antialphaviral activity","volume":"11","author":"Muthu","year":"2025","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2026.03.044_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70069","article-title":"A robust fluorogenic substrate for Chikungunya virus protease (nsP2) activity","volume":"34","author":"Makhaik","year":"2025","journal-title":"Protein Sci"},{"key":"10.1016\/j.apsb.2026.03.044_bib56","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1021\/acs.jmedchem.5c00825","article-title":"Species-dependent metabolism of a covalent nsP2 protease inhibitor with in vivo antialphaviral activity","volume":"68","author":"Hossain","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib57","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1038\/s41598-025-91673-x","article-title":"A covalent chemical probe for Chikungunya nsP2 cysteine protease with antialphaviral activity and proteome-wide selectivity","volume":"15","author":"Ghoshal","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.044_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00649-20","article-title":"Novel class of Chikungunya virus small molecule inhibitors that targets the viral capping machinery","volume":"64","author":"Abdelnabi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2026.03.044_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00463-22","article-title":"MBZM-N-IBT, a novel small molecule, restricts Chikungunya virus infection by targeting nsP2 protease activity in vitro, in vivo, and ex vivo","volume":"66","author":"De","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2026.03.044_bib60","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41565-020-0679-4","article-title":"Programmable multistage drug delivery to lymph nodes","volume":"15","author":"Schudel","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.03.044_bib61","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/ph16111602","article-title":"Synergistic in vitro antiviral effect of combinations of ivermectin, essential oils, and 18-(phthalimid-2-yl) ferruginol against arboviruses and herpesvirus","volume":"16","author":"Betancur-Galvis","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.apsb.2026.03.044_bib62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00775-022-01974-z","article-title":"Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4","volume":"28","author":"Martins","year":"2023","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib63","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1111\/febs.17066","article-title":"In silico identification of Chikungunya virus replication inhibitor validated using biochemical and cell-based approaches","volume":"291","author":"Chaudhary","year":"2024","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2026.03.044_bib64","article-title":"Pyrimidone inhibitors targeting Chikungunya virus nsP3 macrodomain by fragment-based drug design","volume":"16","author":"Zhang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.044_bib65","article-title":"Computational approach towards exploring potential anti-chikungunya activity of selected flavonoids","volume":"6","author":"Seyedi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.044_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81287-0","article-title":"The potential inhibitory mechanism of EGCG against the Chikungunya virus targeting non-structural protein 2 through molecular dynamics simulation","volume":"14","author":"Setyawati","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.044_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01788-20","article-title":"Small-molecule inhibitors of Chikungunya virus: mechanisms of action and antiviral drug resistance","volume":"64","author":"Kovacikova","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2026.03.044_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156359","article-title":"Recent advances in phytocompounds as potential Chikungunya virus non-structural protein 2 protease antagonists: a systematic review","volume":"136","author":"Dansana","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.apsb.2026.03.044_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14790-x","article-title":"Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate","volume":"12","author":"Freire","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.044_bib70","doi-asserted-by":"crossref","first-page":"9961","DOI":"10.1080\/07391102.2023.2254398","article-title":"Identification and molecular docking of novel Chikungunya virus NSP4 inhibitory peptides from camel milk proteins","volume":"42","author":"Alguridi","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.apsb.2026.03.044_bib71","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.antiviral.2017.04.014","article-title":"Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential","volume":"143","author":"Langsjoen","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106186","article-title":"Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo","volume":"239","author":"Verwimp","year":"2025","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2015.12.012","article-title":"Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses","volume":"126","author":"Varghese","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104904","article-title":"Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus","volume":"182","author":"Julander","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib75","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41564-017-0015-4","article-title":"Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation","volume":"2","author":"Chen","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.apsb.2026.03.044_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00420-24","article-title":"4\u2032-Fluorouridine inhibits alphavirus replication and infection in vitro and in vivo","volume":"15","author":"Yin","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.apsb.2026.03.044_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012859","article-title":"Mutations in chikungunya virus nsP4 decrease viral fitness and sensitivity to the broad-spectrum antiviral 4\u2032-fluorouridine","volume":"21","author":"Yin","year":"2025","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2026.03.044_bib78","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/acsinfecdis.0c00915","article-title":"Discovery of a potent and selective chikungunya virus envelope protein inhibitor through computer-aided drug design","volume":"7","author":"Battini","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2026.03.044_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.04.008","article-title":"Molecular basis of arthritogenic alphavirus receptor MXRA8 binding to Chikungunya virus envelope protein","volume":"177","author":"Song","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.03.044_bib80","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.virs.2022.01.032","article-title":"An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses","volume":"37","author":"Ge","year":"2022","journal-title":"Virol Sin"},{"key":"10.1016\/j.apsb.2026.03.044_bib81","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.03.044_bib82","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/v12030314","article-title":"Suramin inhibits Chikungunya virus replication by interacting with virions and blocking the early steps of infection","volume":"12","author":"Albulescu","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2026.03.044_bib83","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.02095-24","article-title":"Generation of RNA aptamers against chikungunya virus E2 envelope protein","volume":"99","author":"Goto","year":"2025","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2026.03.044_bib84","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.3390\/v15112194","article-title":"Identification of 2,4-diaminoquinazoline derivative as a potential small-molecule inhibitor against Chikungunya and ross river viruses","volume":"15","author":"Saha","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2026.03.044_bib85","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.3390\/ijms26136480","article-title":"Potent inhibition of Chikungunya virus entry by a pyrazole-benzene derivative: a computational study targeting the E1-E2 glycoprotein complex","volume":"26","author":"Rahman","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.03.044_bib86","doi-asserted-by":"crossref","first-page":"525","DOI":"10.6026\/97320630019525","article-title":"Insights from the molecular docking analysis of gambogic acid with the Chikungunya spike glycoprotein E2","volume":"19","author":"Qamar","year":"2023","journal-title":"Bioinformation"},{"key":"10.1016\/j.apsb.2026.03.044_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104808","article-title":"Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection","volume":"179","author":"Fatma","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib88","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/0115734099307360240731052835","article-title":"Network pharmacology, molecular docking and in vivo-based analysis on the effects of the MBZM-N-IBT for arthritis","volume":"21","author":"Moharana","year":"2025","journal-title":"Curr Comput Aided Drug Des"},{"key":"10.1016\/j.apsb.2026.03.044_bib89","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01382-20","article-title":"Berberine chloride is an alphavirus inhibitor that targets nucleocapsid assembly","volume":"11","author":"Wan","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.apsb.2026.03.044_bib90","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1021\/acs.jmedchem.5b01047","article-title":"Trisubstituted thieno[3,2-b]pyrrole 5-carboxamides as potent inhibitors of alphaviruses","volume":"58","author":"Ching","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib91","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.virol.2016.08.029","article-title":"Inhibition of chikungunya virus by picolinate that targets viral capsid protein","volume":"498","author":"Sharma","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.apsb.2026.03.044_bib92","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.virol.2017.12.020","article-title":"Structure\u2013function insights into chikungunya virus capsid protein: small molecules targeting capsid hydrophobic pocket","volume":"515","author":"Sharma","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.apsb.2026.03.044_bib93","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1073\/pnas.0804958105","article-title":"Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel","volume":"105","author":"Jing","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.03.044_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007548","article-title":"The effect of amantadine on an ion channel protein from Chikungunya virus","volume":"13","author":"Dey","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.apsb.2026.03.044_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117239","article-title":"The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus","volume":"83","author":"Puhl","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib96","doi-asserted-by":"crossref","first-page":"18820","DOI":"10.1074\/jbc.RA119.010917","article-title":"Regulation of plant ER oxidoreductin 1 (ERO1) activity for efficient oxidative protein folding","volume":"294","author":"Matsusaki","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib97","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00693-16","article-title":"Antagonism of the sodium-potassium ATPase impairs Chikungunya virus infection","volume":"7","author":"Ashbrook","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.apsb.2026.03.044_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009667","article-title":"MK2a inhibitor CMPD1 abrogates Chikungunya virus infection by modulating actin remodeling pathway","volume":"17","author":"Mamidi","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2026.03.044_bib99","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3389\/fimmu.2019.00786","article-title":"P38 and JNK mitogen-activated protein kinases interact with chikungunya virus non-structural protein-2 and regulate TNF induction during viral infection in macrophages","volume":"10","author":"Nayak","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.03.044_bib100","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3724\/abbs.2024073","article-title":"Identification of RACK1 as a novel regulator of non-structural protein 4 of chikungunya virus","volume":"56","author":"Yan","year":"2024","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.apsb.2026.03.044_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008336","article-title":"Bortezomib inhibits chikungunya virus replication by interfering with viral protein synthesis","volume":"14","author":"Kaur","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.apsb.2026.03.044_bib102","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/v15020481","article-title":"Deubiquitinating enzyme inhibitors block chikungunya virus replication","volume":"15","author":"L\u00f3pez","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2026.03.044_bib103","doi-asserted-by":"crossref","DOI":"10.1177\/13596535231155263","article-title":"Inhibition of chikungunya virus replication by N-\u03c9-chloroacetyl-l-ornithine in C6\/36, Vero cells and human fibroblast BJ","volume":"28","author":"Rojas-Luna","year":"2023","journal-title":"Antivir Ther"},{"key":"10.1016\/j.apsb.2026.03.044_bib104","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1128\/AAC.01467-12","article-title":"Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression","volume":"57","author":"Kaur","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2026.03.044_bib105","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/v14061123","article-title":"A novel sphingosine kinase inhibitor suppresses Chikungunya virus infection","volume":"14","author":"Oyewole","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2026.03.044_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03217","article-title":"Coumarin: an emerging antiviral agent","volume":"6","author":"Mishra","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.apsb.2026.03.044_bib107","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2017.12.012","article-title":"Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection","volume":"150","author":"Oo","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/srep11421","article-title":"Antiviral activity of silymarin against chikungunya virus","volume":"5","author":"Lani","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.044_bib109","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ijbiomac.2020.05.165","article-title":"In silico and biophysical investigation of biomolecular interaction between naringin and nsP2 of the chikungunya virus","volume":"160","author":"Tripathi","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.apsb.2026.03.044_bib110","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1186\/1743-422X-8-560","article-title":"Antiviral activity of four types of bioflavonoid against dengue virus type-2","volume":"8","author":"Zandi","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.apsb.2026.03.044_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108045","article-title":"Andrographolide\u2014a prospective remedy for chikungunya fever and viral arthritis","volume":"99","author":"Gupta","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.apsb.2026.03.044_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114110","article-title":"Discovery and development of labdane-oxindole hybrids as small-molecule inhibitors against chikungunya virus infection","volume":"230","author":"Tran","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib113","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2270074","article-title":"The 8-bromobaicalein alleviated Chikungunya-induced musculoskeletal inflammation and reduced the viral load in healthy adult mice","volume":"12","author":"Cao","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.apsb.2026.03.044_bib114","doi-asserted-by":"crossref","DOI":"10.1093\/lambio\/ovaf092","article-title":"Paulownin triazole-chloroquinoline derivative: a promising antiviral candidate against chikungunya virus","volume":"78","author":"Reis","year":"2025","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.apsb.2026.03.044_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104677","article-title":"Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug\u2013target network analysis","volume":"136","author":"Rajput","year":"2021","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.apsb.2026.03.044_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.109989","article-title":"Exploring the potential of direct-acting antivirals against Chikungunya virus through structure-based drug repositioning and molecular dynamic simulations","volume":"189","author":"Kalam","year":"2025","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.apsb.2026.03.044_bib117","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fchem.2019.00071","article-title":"Editorial: Multi-Target-Directed Ligands (MTDL) as challenging research tools in drug discovery: from design to pharmacological evaluation","volume":"7","author":"Alcaro","year":"2019","journal-title":"Front Chem"},{"key":"10.1016\/j.apsb.2026.03.044_bib118","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1002\/anie.201702816","article-title":"Privileged structures revisited","volume":"56","author":"chneider","year":"2017","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2026.03.044_bib119","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1021\/acsinfecdis.2c00108","article-title":"Ligand recognition by the lipid transfer domain of human OSBP is important for enterovirus replication","volume":"8","author":"Kobayashi","year":"2022","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2026.03.044_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104548","article-title":"Differing activities of oxysterol-binding protein (OSBP) targeting anti-viral compounds","volume":"170","author":"Roberts","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib121","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2018.10.005","article-title":"Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms","volume":"159","author":"Ho","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib122","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3390\/pharmaceutics16091111","article-title":"Etravirine prevents west Nile virus and Chikungunya virus infection both in vitro and in vivo by inhibiting viral replication","volume":"16","author":"Zheng","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2026.03.044_bib123","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/acsinfecdis.4c00992","article-title":"Repurposing efavirenz, the HIV antiretroviral drug for Chikungunya virus infection","volume":"11","author":"Nehul","year":"2025","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.apsb.2026.03.044_bib124","doi-asserted-by":"crossref","first-page":"27632","DOI":"10.1021\/acsomega.4c03417","article-title":"In silico drug repurposing uncovered the antiviral potential of the antiparasitic drug oxibendazole against the Chikungunya virus","volume":"9","author":"Rabelo","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.apsb.2026.03.044_bib125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40199-021-00391-y","article-title":"HPLC methods for choloroquine determination in biological samples and pharmaceutical products","volume":"29","author":"Martins","year":"2021","journal-title":"Daru"},{"key":"10.1016\/j.apsb.2026.03.044_bib126","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/0115733971278715231208114037","article-title":"Chikungunya arthritis treatment with Methotrexate and dexamethasone: a randomized, double-blind, placebo-controlled trial","volume":"20","author":"Amaral","year":"2024","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.apsb.2026.03.044_bib127","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3389\/fimmu.2018.01510","article-title":"Janus kinase inhibitor baricitinib modulates human innate and adaptive immune system","volume":"9","author":"Kubo","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.03.044_bib128","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1007\/s11030-025-11131-8","article-title":"Drug repositioning as a promising approach for the eradication of emerging and re-emerging viral agents","volume":"29","author":"Almulhim","year":"2025","journal-title":"Mol Divers"},{"key":"10.1016\/j.apsb.2026.03.044_bib129","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1128\/JVI.00998-15","article-title":"Expanding regulatory T cells alleviates chikungunya virus-induced pathology in mice","volume":"89","author":"Lee","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2026.03.044_bib130","article-title":"Virus infection drives IL-2 antibody complexes into pro-inflammatory agonists in mice","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.044_bib131","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/imm.12008","article-title":"Interleukin-2\/anti-interleukin-2 monoclonal antibody immune complex suppresses collagen-induced arthritis in mice by fortifying interleukin-2\/STAT5 signalling pathways","volume":"137","author":"Lee","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.apsb.2026.03.044_bib132","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12985-023-02271-0","article-title":"Repurposed drugs in combinations exert additive anti-chikungunya virus activity: an in-vitro study","volume":"21","author":"Davuluri","year":"2024","journal-title":"Virol J"},{"key":"10.1016\/j.apsb.2026.03.044_bib133","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6026\/97320630015439","article-title":"Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya virus: a drug repositioning approach","volume":"15","author":"Agarwal","year":"2019","journal-title":"Bioinformation"},{"key":"10.1016\/j.apsb.2026.03.044_bib134","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.virol.2020.05.010","article-title":"Evaluation of novobiocin and telmisartan for anti-CHIKV activity","volume":"548","author":"Tripathi","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.apsb.2026.03.044_bib135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbrc.2022.11.013","article-title":"Identification of the corticotropin-releasing factor receptor 1 antagonists as inhibitors of Chikungunya virus replication using a Gaussia luciferase-expressing subgenomic replicon","volume":"637","author":"Watanabe","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2026.03.044_bib136","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1016\/j.apsb.2021.02.023","article-title":"Gains from no real PAINS: where 'Fair Trial Strategy' stands in the development of multi-target ligands","volume":"11","author":"Sun","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.044_bib137","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.apsb.2021.08.027","article-title":"Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors","volume":"12","author":"Gao","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.044_bib138","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.apsb.2023.08.004","article-title":"Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors","volume":"14","author":"Song","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.044_bib139","unstructured":"Bassetto M, Brancale A. Chapter Four\u2014The search for antivirals to treat alphavirus infections. In: Seley-Radtke Keditor. Coronaviruses and other novel antiviral targets, annual reports in medicinal chemistry. Academic Press. pp. 133\u2013151."},{"key":"10.1016\/j.apsb.2026.03.044_bib140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10989-020-10072-0","article-title":"Antiviral peptides: identification and validation","volume":"27","author":"Agarwal","year":"2021","journal-title":"Int J Pept Res Ther"},{"key":"10.1016\/j.apsb.2026.03.044_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028923","article-title":"Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays","volume":"6","author":"Pohjala","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.044_bib142","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/cbdd.12621","article-title":"Discovery of novel peptidomimetics as irreversible CHIKV NsP2 protease inhibitors using quantum mechanical-based ligand descriptors","volume":"86","author":"El-labbad","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.apsb.2026.03.044_bib143","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1080\/07391102.2016.1261046","article-title":"Conformer and pharmacophore based identification of peptidomimetic inhibitors of chikungunya virus nsP2 protease","volume":"35","author":"Dhindwal","year":"2017","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.apsb.2026.03.044_bib144","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00894-022-05316-3","article-title":"Structural insights into the inhibition of the nsP2 protease from Chikungunya virus by molecular modeling approaches","volume":"28","author":"Rabelo","year":"2022","journal-title":"J Mol Model"},{"key":"10.1016\/j.apsb.2026.03.044_bib145","doi-asserted-by":"crossref","first-page":"525","DOI":"10.6026\/97320630019525","article-title":"Insights from the molecular docking analysis of gambogic acid with the Chikungunya spike glycoprotein E2","volume":"19","author":"Qamar","year":"2023","journal-title":"Bioinformation"},{"key":"10.1016\/j.apsb.2026.03.044_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07777","article-title":"Potential of diterpene compounds as antivirals, a review","volume":"7","author":"Wardana","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.apsb.2026.03.044_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.07.006","article-title":"Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope","volume":"184","author":"Kim","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.03.044_bib148","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12250-019-00135-y","article-title":"Development of a specific CHIKV-E2 monoclonal antibody for Chikungunya diagnosis","volume":"34","author":"Kim","year":"2019","journal-title":"Virol Sin"},{"key":"10.1016\/j.apsb.2026.03.044_bib149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002423","article-title":"A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease","volume":"7","author":"Selvarajah","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.apsb.2026.03.044_bib150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003312","article-title":"Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus","volume":"9","author":"Pal","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2026.03.044_bib151","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cell.2015.10.050","article-title":"Broadly neutralizing alphavirus antibodies bind an epitope on E2 and inhibit entry and egress","volume":"163","author":"Fox","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.03.044_bib152","doi-asserted-by":"crossref","first-page":"27637","DOI":"10.1073\/pnas.2008051117","article-title":"Structural basis of Chikungunya virus inhibition by monoclonal antibodies","volume":"117","author":"Zhou","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.03.044_bib153","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.4049\/jimmunol.1003139","article-title":"Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency","volume":"186","author":"Warter","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.03.044_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008061","article-title":"Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins","volume":"15","author":"Quiroz","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2026.03.044_bib155","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav5062","article-title":"Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc\u2013Fc\u03b3R interaction on monocytes","volume":"4","author":"Fox","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.apsb.2026.03.044_bib156","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41541-018-0095-z","article-title":"From therapeutic antibodies to immune complex vaccines","volume":"4","author":"Wang","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.apsb.2026.03.044_bib157","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.03.044_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101142","article-title":"Role of nanotechnology behind the success of mRNA vaccines for COVID-19","volume":"38","author":"Khurana","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2026.03.044_bib159","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticlesfrom liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.03.044_bib160","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","article-title":"COVID-19 vaccine development and a potential nanomaterial path forward","volume":"15","author":"Shin","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.03.044_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2019.105131","article-title":"A patent perspective on chikungunya","volume":"199","author":"Dapurkar","year":"2019","journal-title":"Acta Trop"},{"key":"10.1016\/j.apsb.2026.03.044_bib162","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/17460794.2.2.121","article-title":"Re-emergence of the Knotty Chikungunya virus: facts, fear or fiction","volume":"2","author":"Saxena","year":"2007","journal-title":"Future Virol"},{"key":"10.1016\/j.apsb.2026.03.044_bib163","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-1-62703-484-5_32","article-title":"Development of a high-throughput antiviral assay for screening inhibitors of chikungunya virus and generation of drug-resistant mutations in cultured cells","volume":"1030","author":"Gong","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.apsb.2026.03.044_bib164","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.03.044_bib165","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","article-title":"COVID-19 vaccine development and a potential nanomaterial path forward","volume":"15","author":"Shin","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.03.044_bib166","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3390\/v16091489","article-title":"RNAi-induced gene silencing against Chikungunya and COVID-19: what have we learned so far, and what is the way forward?","volume":"16","author":"Panda","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2026.03.044_bib167","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11320","article-title":"A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs","volume":"7","author":"Karlas","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.03.044_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106539","article-title":"Novel molecular approaches to combat vectors and vector-borne viruses: special focus on RNA interference (RNAi) mechanisms","volume":"233","author":"Agarwal","year":"2022","journal-title":"Acta Trop"},{"key":"10.1016\/j.apsb.2026.03.044_bib169","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/nbt1118","article-title":"Design of a genome-wide siRNA library using an artificial neural network","volume":"23","author":"Huesken","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.03.044_bib170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12951-022-01417-6","article-title":"Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca na\u00efve phage display library","volume":"20","author":"Li","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.apsb.2026.03.044_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105523","article-title":"Inhibition of Chikungunya virus genome replication by targeting essential RNA structures within the virus genome","volume":"211","author":"Prosser","year":"2023","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.crchbi.2022.100021","article-title":"Recent advances on therapeutic potentials of gold and silver nanobiomaterials for human viral diseases","volume":"2","author":"Ayipo","year":"2022","journal-title":"Curr Res Chem Biol"},{"key":"10.1016\/j.apsb.2026.03.044_bib173","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/acsnano.7b06934","article-title":"Silver nanoparticles impair retinoic acid-inducible gene I-mediated mitochondrial antiviral immunity by blocking the autophagic flux in lung epithelial cells","volume":"12","author":"Villeret","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.03.044_bib174","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12033-024-01052-6","article-title":"Recent advances in the role of different nanoparticles in the various biosensors for the detection of the Chikungunya virus","volume":"67","author":"Shahrtash","year":"2025","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.apsb.2026.03.044_bib175","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/bios14070344","article-title":"Aptamer based on silver nanoparticle-modified flexible carbon ink printed electrode for the electrochemical detection of Chikungunya virus","volume":"14","author":"Sharma","year":"2024","journal-title":"Biosensors"},{"key":"10.1016\/j.apsb.2026.03.044_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.105848","article-title":"Nanotechnology as a tool for detection and treatment of arbovirus infections","volume":"216","author":"Duarte","year":"2021","journal-title":"Acta Trop"},{"key":"10.1016\/j.apsb.2026.03.044_bib177","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/acssensors.1c02232","article-title":"Detection of glial fibrillary acidic protein in patient plasma using on-chip graphene field-effect biosensors, in comparison with ELISA and single-molecule array","volume":"7","author":"Xu","year":"2022","journal-title":"ACS Sens"},{"key":"10.1016\/j.apsb.2026.03.044_bib178","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.3390\/v14122821","article-title":"Nanomechanical and vibrational signature of Chikungunya viral particles","volume":"14","author":"Cardoso-Lima","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2026.03.044_bib179","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijid.2016.02.895","article-title":"Vaccines for emerging infections: chikungunya vaccine","volume":"45","author":"Kandaswamy","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.apsb.2026.03.044_bib180","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02566-20","article-title":"Structural insights into the mechanisms of action of functionally distinct classes of Chikungunya virus nonstructural protein 1 inhibitors","volume":"65","author":"Kovacikova","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2026.03.044_bib181","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01470-20","article-title":"Interdomain flexibility of Chikungunya virus nsP2 helicase-protease differentially influences viral RNA replication and infectivity","volume":"95","author":"Law","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2026.03.044_bib182","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1073\/pnas.1900656116","article-title":"Structural insights into RNA recognition by the Chikungunya virus nsP2 helicase","volume":"116","author":"Law","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.03.044_bib183","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/13543776.2020.1751817","article-title":"Antiviral therapeutics for chikungunya virus","volume":"30","author":"Ghildiyal","year":"2020","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.apsb.2026.03.044_bib184","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bbrc.2017.07.157","article-title":"Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus","volume":"491","author":"Lu","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2026.03.044_bib185","article-title":"Drug repurposing approach against chikungunya virus: an in vitro and in silico study","volume":"13","author":"Kasabe","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.apsb.2026.03.044_bib186","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1335189","article-title":"Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics","volume":"14","author":"Davuluri","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.apsb.2026.03.044_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106186","article-title":"Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo","volume":"239","author":"Verwimp","year":"2025","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2026.03.044_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2025.101614","article-title":"Novel and repurposed antiviral molecules for arbovirus infections with epidemic potential: a systematic review","volume":"66","author":"Logiudice","year":"2025","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.apsb.2026.03.044_bib189","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30647-8","article-title":"Exploring scenarios of chikungunya mitigation with a data-driven agent-based model of the 2014-2016 outbreak in Colombia","volume":"8","author":"Espa\u00f1a","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.044_bib190","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3390\/microorganisms9091998","article-title":"A mouse model for studying post-acute arthritis of Chikungunya","volume":"9","author":"Chang","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.apsb.2026.03.044_bib191","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1092370","article-title":"Chikungunya patient transcriptional signatures faithfully recapitulated in a C57BL\/6J mouse model","volume":"13","author":"Bishop","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.03.044_bib192","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008910","article-title":"Adenovirus vectored IFN-\u03b1 protects mice from lethal challenge of Chikungunya virus infection","volume":"14","author":"Chen","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.apsb.2026.03.044_bib193","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001446","article-title":"Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia","volume":"6","author":"Dupuis-Maguiraga","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.apsb.2026.03.044_bib194","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1007\/s12325-021-01867-8","article-title":"Budget impact of sequential treatment with biologics, biosimilars, and targeted synthetic disease-modifying antirheumatic drugs in thai patients with rheumatoid arthritis","volume":"38","author":"Osiri","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.apsb.2026.03.044_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101672","article-title":"An evaluation of global Chikungunya clinical management guidelines: a systematic review","volume":"54","author":"Webb","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.apsb.2026.03.044_bib196","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.drudis.2019.01.005","article-title":"Orphan drugs: major development challenges at the clinical stage","volume":"24","author":"Fonseca","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2026.03.044_bib197","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007880","article-title":"Systems analysis of subjects acutely infected with the Chikungunya virus","volume":"15","author":"Soares-Schanoski","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2026.03.044_bib198","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2215\/CJN.0000000000000167","article-title":"Overcoming barriers to drug development in children with CKD","volume":"18","author":"Khurana","year":"2023","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"10.1016\/j.apsb.2026.03.044_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2025.102068","article-title":"Chikungunya and other viral arthritis","volume":"39","author":"Chopra","year":"2025","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.apsb.2026.03.044_bib200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110538","article-title":"Chikungunya viral fitness measures within the vector and subsequent transmission potential","volume":"9","author":"Christofferson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.044_bib201","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.virol.2017.02.014","article-title":"Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of Chikungunya virus","volume":"505","author":"Wada","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.apsb.2026.03.044_bib202","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20110996","article-title":"Chikungunya virus-induced autophagy delays caspase-dependent cell death","volume":"209","author":"Joubert","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2026.03.044_bib203","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaf067","article-title":"Immunomodulatory therapy of chikungunya arthritis: systematic review and meta-analysis","volume":"32","author":"Amaral","year":"2025","journal-title":"J Travel Med"},{"key":"10.1016\/j.apsb.2026.03.044_bib204","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1038\/d41586-019-03638-6","article-title":"Tailoring vaccines for older people and the very young","volume":"575","author":"Keener","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.03.044_bib205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: which therapy for which patient: focus on special populations and chronic infections","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.apsb.2026.03.044_bib206","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246319","article-title":"In vitro study of hesperetin and hesperidin as inhibitors of Zika and Chikungunya virus proteases","volume":"16","author":"Eberle","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.044_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114534","article-title":"Recent progress of microfluidic technology for pharmaceutical analysis","volume":"209","author":"Jia","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.apsb.2026.03.044_bib208","series-title":"2021 IEEE\/ACM international conference on computer aided design (ICCAD)","first-page":"1","article-title":"Relative-scheduling-based high-level synthesis for flow-based microfluidic biochips","author":"Zuo","year":"2021"},{"key":"10.1016\/j.apsb.2026.03.044_bib209","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s13770-022-00449-1","article-title":"Re-cellularised kidney scaffold for Chikungunya virus propagation: a novel approach","volume":"19","author":"Walawalkar","year":"2022","journal-title":"Tissue Eng Regen Med"},{"key":"10.1016\/j.apsb.2026.03.044_bib210","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","article-title":"Preparation and application of pH-responsive drug delivery systems","volume":"348","author":"Ding","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.03.044_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110466","article-title":"Smart drug delivery system activated by specific biomolecules","volume":"108","author":"Constantin","year":"2020","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.apsb.2026.03.044_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116871","article-title":"Smart stimuli-responsive drug delivery systems based on cyclodextrin: a review","volume":"251","author":"Tian","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.apsb.2026.03.044_bib213","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/pharmaceutics14030672","article-title":"Strategies for targeted delivery of exosomes to the brain: advantages and challenges","volume":"14","author":"Choi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2026.03.044_bib214","article-title":"Computational approach towards exploring potential anti-chikungunya activity of selected flavonoids","volume":"6","author":"Seyedi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.044_bib215","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1021\/acs.jmedchem.5b01047","article-title":"Trisubstituted thieno[3,2-b]pyrrole 5-carboxamides as potent inhibitors of alphaviruses","volume":"58","author":"Ching","year":"2015","journal-title":"J Med Chem"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526002042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526002042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:26:58Z","timestamp":1783034818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526002042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":215,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2211383526002042"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.044","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in antiviral drugs for Chikungunya virus (CHIKV): Targets, mechanisms, and development strategies","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}